Literature DB >> 16996918

Early cavopulmonary anastomosis after Norwood procedure results in excellent Fontan outcome.

Robert D B Jaquiss1, Stephanie L Siehr, Nancy S Ghanayem, George M Hoffman, Raymond T Fedderly, Joseph R Cava, Kathy A Mussatto, James S Tweddell.   

Abstract

BACKGROUND: Children with univentricular hearts and aortic arch obstruction are treated sequentially with Norwood procedure, superior cavopulmonary anastomosis (SCPA), and Fontan operation. Early SCPA results in lower initial O2 saturation and longer hospitalization, but not increased mortality. We sought to determine the impact of early SCPA on Fontan candidacy and outcomes.
METHODS: Eighty-five consecutive patients undergoing Norwood operation between January 1998 and February 2003 were divided into group 1 (SCPA at less than 4 months, n = 33) and group 2 (SCPA at more than 4 months, n = 52). Of the original cohort, 69 have undergone Fontan operation, 7 await Fontan, 1 was transplanted, 3 are not Fontan candidates, and 5 died late after SCPA. Group 1 (n = 25) and group 2 (n = 44) patients who have completed Fontan operation were compared for preoperative and perioperative variables: age, size, O2 saturation, pulmonary artery pressure and size, prevalence of tricuspid regurgitation and ventricular dysfunction, extubation rate in operating room, duration of pleural drainage, hospital stay, and discharge O2 saturation. Late functional status and ventricular function were also compared. Survival was compared for original groups 1 and 2.
RESULTS: There were no differences for any preoperative or perioperative variable, or late functional assessment. Actuarial survival at 6 years was also not different (88% +/- 5% for group 1 and 94% +/- 4% for group 2, p = 0.72).
CONCLUSIONS: Although initially more cyanotic and hospitalized longer than older peers, younger SCPA patients achieve clinical equivalence by the time of Fontan operation and afterward. We conclude that both short- and long-term outcomes support performance of early SCPA.

Entities:  

Mesh:

Year:  2006        PMID: 16996918     DOI: 10.1016/j.athoracsur.2006.04.095

Source DB:  PubMed          Journal:  Ann Thorac Surg        ISSN: 0003-4975            Impact factor:   4.330


  9 in total

1.  Fate of ventricular and valve performance following early bidirectional Glenn procedure after Norwood operation controlled for hypoplastic left heart syndome anatomic subtype.

Authors:  Anastasios C Polimenakos; John W Bokowski; Hani S Ghawi; Chawki F El-Zein; Michel N Ilbawi
Journal:  Pediatr Cardiol       Date:  2013-10-15       Impact factor: 1.655

2.  The Optimal Timing of Stage-2-Palliation After the Norwood Operation.

Authors:  James M Meza; Edward Hickey; Brian McCrindle; Eugene Blackstone; Brett Anderson; David Overman; James K Kirklin; Tara Karamlou; Christopher Caldarone; Richard Kim; William DeCampli; Marshall Jacobs; Kristine Guleserian; Jeffrey P Jacobs; Robert Jaquiss
Journal:  Ann Thorac Surg       Date:  2017-08-25       Impact factor: 4.330

3.  Impact of Characteristics at Stage-2-Palliation on Outcome Following Fontan Completion.

Authors:  Keti Vitanova; Shuichi Shiraishi; Benedikt Mayr; Elisabeth Beran; Julie Cleuziou; Martina Strbad; Christoph Röhlig; Alfred Hager; Jürgen Hörer; Rüdiger Lange; Masamichi Ono
Journal:  Pediatr Cardiol       Date:  2019-07-24       Impact factor: 1.655

4.  Superior cavopulmonary anastomosis timing and outcomes in infants with single ventricle.

Authors:  James F Cnota; Kerstin R Allen; Steven Colan; Wesley Covitz; Eric M Graham; David A Hehir; Jami C Levine; Renee Margossian; Brian W McCrindle; L LuAnn Minich; Shobha Natarajan; Marc E Richmond; Daphne T Hsu
Journal:  J Thorac Cardiovasc Surg       Date:  2012-08-28       Impact factor: 5.209

5.  Risk factors for failed staged palliation after bidirectional Glenn in infants who have undergone stage one palliation.

Authors:  Kevin G Friedman; Joshua W Salvin; David Wypij; Yared Gurmu; Emile A Bacha; David W Brown; Peter C Laussen; Mark A Scheurer
Journal:  Eur J Cardiothorac Surg       Date:  2011-03-05       Impact factor: 4.191

Review 6.  Hypoplastic left heart syndrome: current considerations and expectations.

Authors:  Jeffrey A Feinstein; D Woodrow Benson; Anne M Dubin; Meryl S Cohen; Dawn M Maxey; William T Mahle; Elfriede Pahl; Juan Villafañe; Ami B Bhatt; Lynn F Peng; Beth Ann Johnson; Alison L Marsden; Curt J Daniels; Nancy A Rudd; Christopher A Caldarone; Kathleen A Mussatto; David L Morales; D Dunbar Ivy; J William Gaynor; James S Tweddell; Barbara J Deal; Anke K Furck; Geoffrey L Rosenthal; Richard G Ohye; Nancy S Ghanayem; John P Cheatham; Wayne Tworetzky; Gerard R Martin
Journal:  J Am Coll Cardiol       Date:  2012-01-03       Impact factor: 24.094

7.  Choices doctors would make if their infant had hypoplastic left heart syndrome: comparison of survey data from 1999 and 2007.

Authors:  Alexander A Kon; Milan Prsa; Charles V Rohlicek
Journal:  Pediatr Cardiol       Date:  2012-08-15       Impact factor: 1.655

8.  The Optimal Timing of Stage 2 Palliation for Hypoplastic Left Heart Syndrome: An Analysis of the Pediatric Heart Network Single Ventricle Reconstruction Trial Public Data Set.

Authors:  James M Meza; Edward J Hickey; Eugene H Blackstone; Robert D B Jaquiss; Brett R Anderson; William G Williams; Sally Cai; Glen S Van Arsdell; Tara Karamlou; Brian W McCrindle
Journal:  Circulation       Date:  2017-07-07       Impact factor: 29.690

9.  Interstage mortality for functional single ventricle with heterotaxy syndrome: a retrospective study of the clinical experience of a single tertiary center.

Authors:  Jinyoung Song; I-Seok Kang; June Huh; Ok Jeong Lee; Geena Kim; Tae Gook Jun; Ji Hyuk Yang
Journal:  J Cardiothorac Surg       Date:  2013-04-16       Impact factor: 1.637

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.